CVRx | Barostim Email Format
Medical Equipment ManufacturingMinnesota, United States201-500 Employees
CVRx, also known as Barostim, is a medical devices company based in Minneapolis, Minnesota, publicly traded on NASDAQ as CVRX. The company has developed implantable technology for the treatment of high blood pressure and heart failure. Barostim activates the carotid baroreceptors, engaging the body's natural blood flow regulation system to influence cardiovascular function. Barostim is a prescriptive device, requiring clinician prescription and consideration of potential benefits and risks in its use. The company operates in the medical equipment manufacturing industry, aiming to address cardiovascular conditions through its device-based therapy. In 2026 CVRx announced plans to present at several industry conferences, including Goldman Sachs' Global Healthcare Conference, signaling continued outreach to clinicians and investors.